In line with this study showing the association between higher serum HMGB1 levels and a higher risk of postoperative AE, we have previously reported that higher levels of HMGB1 are associated with an earlier onset of cytotoxic chemotherapy-induced lung injury in patients with advanced lung cancer and ILD11. Here, HMGB1 is linked to lung carcinoma.